Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A fungicidal monoclonal antibody protects against murine invasive candidiasis.

Literature DB >> 16622248

A fungicidal monoclonal antibody protects against murine invasive candidiasis.

María J Sevilla¹, Beatriz Robledo, Aitor Rementeria, María D Moragues, José Pontón.

Abstract

Mice infected by Candida albicans and treated with monoclonal antibody C7 survived longer than saline-treated animals. A prozone-like effect was observed. The in vitro candidacidal activity of macrophages was strongly enhanced when C. albicans was opsonized by C7 and complete murine serum was present.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2006 PMID： 16622248 PMCID： PMC1459740 DOI： 10.1128/IAI.74.5.3042-3045.2006

Source DB: PubMed Journal: Infect Immun ISSN： 0019-9567 Impact factor: 3.441

17 in total

1. Disruption in Candida albicans of the TPS2 gene encoding trehalose-6-phosphate phosphatase affects cell integrity and decreases infectivity.

Authors: Oscar Zaragoza; Claudio de Virgilio; José Pontón; Carlos Gancedo
Journal: Microbiology Date: 2002-05 Impact factor: 2.777

2. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors: T Mosmann
Journal: J Immunol Methods Date: 1983-12-16 Impact factor: 2.303

3. Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats.

Authors: F De Bernardis; M Boccanera; D Adriani; E Spreghini; G Santoni; A Cassone
Journal: Infect Immun Date: 1997-08 Impact factor: 3.441

4. Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis.

Authors: R C Matthews; J P Burnie; D Howat; T Rowland; F Walton
Journal: Immunology Date: 1991-09 Impact factor: 7.397

5. A monoclonal antibody to Candida albicans enhances mouse neutrophil candidacidal activity.

Authors: T C Caesar-TonThat; J E Cutler
Journal: Infect Immun Date: 1997-12 Impact factor: 3.441

6. Biological activities of naturally occurring antibodies reactive with Candida albicans mannan.

Authors: Thomas R Kozel; Randall S MacGill; Ann Percival; Qing Zhou
Journal: Infect Immun Date: 2004-01 Impact factor: 3.441

7. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.

Authors: Carla Bromuro; Antonella Torosantucci; Paola Chiani; Stefania Conti; Luciano Polonelli; Antonio Cassone
Journal: Infect Immun Date: 2002-10 Impact factor: 3.441

8. A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.

Authors: María D Moragues; Miren J Omaetxebarria; Natalia Elguezabal; María J Sevilla; Stefania Conti; Luciano Polonelli; José Pontón
Journal: Infect Immun Date: 2003-09 Impact factor: 3.441

Review 9. Genetically recombinant antibodies: new therapeutics against candidiasis.

Authors: James Burnie; Ruth Matthews
Journal: Expert Opin Biol Ther Date: 2004-02 Impact factor: 4.388

10. Antibody response that protects against disseminated candidiasis.

Authors: Y Han; J E Cutler
Journal: Infect Immun Date: 1995-07 Impact factor: 3.441

14 in total

1. Fungicidal monoclonal antibody C7 interferes with iron acquisition in Candida albicans.

Authors: Sonia Brena; Jonathan Cabezas-Olcoz; María D Moragues; Iñigo Fernández de Larrinoa; Angel Domínguez; Guillermo Quindós; José Pontón
Journal: Antimicrob Agents Chemother Date: 2011-04-25 Impact factor: 5.191

Review 2. Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma.

Authors: Arturo Casadevall; Liise-anne Pirofski
Journal: Infect Immun Date: 2007-08-20 Impact factor: 3.441

3. Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax.

Authors: Lisa Winterroth; Johanna Rivera; Antonio S Nakouzi; Ekaterina Dadachova; Arturo Casadevall
Journal: Infect Immun Date: 2010-04-12 Impact factor: 3.441

Review 4. Candida albicans Als3, a multifunctional adhesin and invasin.

Authors: Yaoping Liu; Scott G Filler
Journal: Eukaryot Cell Date: 2010-11-29

Review 5. Advances in combating fungal diseases: vaccines on the threshold.

Authors: Jim E Cutler; George S Deepe; Bruce S Klein
Journal: Nat Rev Microbiol Date: 2006-12-11 Impact factor: 60.633

6. Antibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity.

Authors: Elena Gabrielli; Eva Pericolini; Elio Cenci; Federica Ortelli; Walter Magliani; Tecla Ciociola; Francesco Bistoni; Stefania Conti; Anna Vecchiarelli; Luciano Polonelli
Journal: PLoS One Date: 2009-12-04 Impact factor: 3.240

7. Fungicidal monoclonal antibody C7 binds to Candida albicans Als3.

Authors: Sonia Brena; Miren J Omaetxebarría; Natalia Elguezabal; Jonathan Cabezas; María D Moragues; José Pontón
Journal: Infect Immun Date: 2007-04-23 Impact factor: 3.441

Review 8. Attempts at a peptide vaccine against paracoccidioidomycosis, adjuvant to chemotherapy.

Authors: Luiz R Travassos; Elaine G Rodrigues; Leo K Iwai; Carlos P Taborda
Journal: Mycopathologia Date: 2008 Apr-May Impact factor: 2.574

9. Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis.

Authors: Hong Xin; Sebastian Dziadek; David R Bundle; Jim E Cutler
Journal: Proc Natl Acad Sci U S A Date: 2008-08-25 Impact factor: 11.205

10. Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence.

Authors: Antonella Torosantucci; Paola Chiani; Carla Bromuro; Flavia De Bernardis; Angelina S Palma; Yan Liu; Giuseppina Mignogna; Bruno Maras; Marisa Colone; Annarita Stringaro; Silvia Zamboni; Ten Feizi; Antonio Cassone
Journal: PLoS One Date: 2009-04-28 Impact factor: 3.240